The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

The self-styled sommelier of horror wants to create new franchises and new characters, push boundaries, and give fans a slice of the bloody pie: "What matters in horror is the intellectual property." ...

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

On this episode of The Vet Blast Podcast presented by dvm360, Adam Christman, DVM, MBA, and Tyler Primavera, DVM, explore the ...

Eli Manning has more game than just being a quarterback. The former New York Giants star took on women's basketball icon Caitlin Clark in Pop-A-Shot and downed the Indiana Fever star. The players ...

Novo Nordisk’s Wegovy (semaglutide) and Eli Lilly’s Zepbound (tirzepatide) quickly reached blockbuster status within their ...

Eli Lilly tags Triangle for long-term growth 2024 Space Awards: Economic Development – Existing Industry 2024 Space Awards: Economic Development – Existing Industry $2B campus marks fresh ...